Skip to main content
logo
MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.210
+0.040 (3.42%)
May 29, 2026, 4:00 PM EDT - Market closed

MaxCyte Revenue

MaxCyte had revenue of $9.65M in the quarter ending March 31, 2026, a decrease of -7.11%. This brings the company's revenue in the last twelve months to $32.29M, down -14.30% year-over-year. In the year 2025, MaxCyte had annual revenue of $33.03M, down -14.50%.

Revenue (ttm)
$32.29M
Revenue Growth
-14.30%
P/S Ratio
4.01
Revenue / Employee
$354,802
Employees
91
Market Cap
129.62M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.03M-5.60M-14.50%
Dec 31, 202438.63M-2.66M-6.44%
Dec 31, 202341.29M-2.97M-6.72%
Dec 31, 202244.26M10.37M30.59%
Dec 31, 202133.89M7.73M29.52%
Dec 31, 202026.17M4.55M21.04%
Dec 31, 201921.62M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Inogen351.50M
Neuronetics151.64M
Quanterix144.98M
Owlet107.06M
AVITA Medical72.35M
CVRx, Inc.59.07M
Apyx Medical55.90M
SANUWAVE Health44.34M
Revenue Rankings

MXCT News

More News